drugset / Trial / NCT03147599

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

NCT03147599 ↗

Phase 4 Completed 110 enrolled Mansoura University
RandomizedParallel-groupSingle-blindTreatment

Summary

A randomized controlled trial to assess clinically the efficacy of the selective ileum spasmolytic mebeverine on daytime incontinence and nocturnal enuresis of orthotopic w-ileal neobladders and quality of life effect within 1 year post-surgery.

Timeline

Start
2017-05-15
Primary completion
2019-05-01
Completion
2019-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Coloverin Unknown 135 mg —